相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Macrolides for the therapy of nosocomial infections
Maria Mouktaroudi et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2012)
The immune response to severe bacterial infections: consequences for therapy
Evangelos J. Giamarellos-Bourboulis et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2012)
COMPARISON OF MORTALITY ASSOCIATED WITH SEPSIS IN THE BURN, TRAUMA, AND GENERAL INTENSIVE CARE UNIT PATIENT: A SYSTEMATIC REVIEW OF THE LITERATURE
Elizabeth A. Mann et al.
SHOCK (2012)
Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients
Olivier Lortholary et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Prospective Multicenter Study of the Epidemiology, Molecular Identification, and Antifungal Susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis Isolated from Patients with Candidemia
Emilia Canton et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Cost-Effectiveness Analysis of Polymyxin-B Immobilized Fiber Column and Conventional Medical Therapy in the Management of Abdominal Septic Shock in Italy
Patrizia Berto et al.
BLOOD PURIFICATION (2011)
Nationwide Trends of Severe Sepsis in the 21st Century (2000-2007)
Gagan Kumar et al.
CHEST (2011)
The epidemiology of sepsis in Colombia: A prospective multicenter cohort study in ten university hospitals
Ferney Rodriguez et al.
CRITICAL CARE MEDICINE (2011)
Assessment of plasmatic immunoglobulin G, A and M levels in septic shock patients
Fabienne Venet et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Enteral Omega-3 Fatty Acid, γ-Linolenic Acid, and Antioxidant Supplementation in Acute Lung Injury
Todd W. Rice et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Effectiveness and safety of macrolides in cystic fibrosis patients: a meta-analysis and systematic review
Yun Cai et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia
Qin Lu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial
Sabine C. A. Meijvis et al.
LANCET (2011)
ELPylated anti-human TNF therapeutic single-domain antibodies for prevention of lethal septic shock
Udo Conrad et al.
PLANT BIOTECHNOLOGY JOURNAL (2011)
Adjunctive corticosteroid therapy in pediatric severe sepsis: Observations from the RESOLVE study
Jerry J. Zimmerman et al.
PEDIATRIC CRITICAL CARE MEDICINE (2011)
Low-dose hydrocortisone treatment for patients with septic shock: A pilot study comparing 3 days with 7 days
Jin Won Huh et al.
RESPIROLOGY (2011)
COMBINATION OF IMIPENEM AND TAK-242, A TOLL-LIKE RECEPTOR 4 SIGNAL TRANSDUCTION INHIBITOR, IMPROVES SURVIVAL IN A MURINE MODEL OF POLYMICROBIAL SEPSIS
Takukyu Sha et al.
SHOCK (2011)
Pathophysiological aspects of hyperglycemia in children with meningococcal sepsis and septic shock: a prospective, observational cohort study
Jennifer J. Verhoeven et al.
CRITICAL CARE (2011)
Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study
Kazuma Yamakawa et al.
CRITICAL CARE (2011)
Inhibition of caspase-1 activation in gram-negative sepsis and experimental endotoxemia
Evangelos J. Giamarellos-Bourboulis et al.
CRITICAL CARE (2011)
Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis
Lulong Bo et al.
CRITICAL CARE (2011)
Epidemiologic Trend of Severe Sepsis in Taiwan From 1997 Through 2006
Hsiu-Nien Shen et al.
CHEST (2010)
A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis
Todd W. Rice et al.
CRITICAL CARE MEDICINE (2010)
Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: A propensity-matched analysis
Anand Kumar et al.
CRITICAL CARE MEDICINE (2010)
Effects of sepsis on neutrophil chemotaxis
Raju C. Reddy et al.
CURRENT OPINION IN HEMATOLOGY (2010)
Ex-vivo effect of dexamethasone on cytokine production from whole blood of septic patients: Correlation with disease severity
Evangelos J. Giamarellos-Bourboulis et al.
CYTOKINE (2010)
Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia
I. Martin-Loeches et al.
INTENSIVE CARE MEDICINE (2010)
Effects of pentoxifylline on coagulation profile and disseminated intravascular coagulation incidence in Egyptian septic neonates
M. Adel et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2010)
Pharmacokinetics and lung distribution of a humanized anti-RAGE antibody in wild-type and RAGE-/- mice
Yulia Vugmeyster et al.
MABS (2010)
APHERESIS OF ACTIVATED LEUKOCYTES WITH AN IMMOBILIZED POLYMYXIN B FILTER IN PATIENTS WITH SEPTIC SHOCK
Tuneyasu Kumagai et al.
SHOCK (2010)
Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection
Charalambos Gogos et al.
CRITICAL CARE (2010)
Innate IL-17-producing cells: the sentinels of the immune system
Daniel J. Cua et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Effectiveness of Treatments for Severe Sepsis A Prospective, Multicenter, Observational Study
Ricard Ferrer et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Granulocyte-Macrophage Colony-stimulating Factor to Reverse Sepsis-associated Immunosuppression A Double-Blind, Randomized, Placebo-controlled Multicenter Trial
Christian Meisel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Tight glycemic control may favor fibrinolysis in patients with sepsis
Monica Savioli et al.
CRITICAL CARE MEDICINE (2009)
Recombinant human soluble thrombomodulin decreases the plasma high-mobility group box-1 protein levels, whereas improving the acute liver injury and survival rates in experimental endotoxemia
Masaru Nagato et al.
CRITICAL CARE MEDICINE (2009)
Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia
M. I. Restrepo et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Lipopolysaccharide-Trap-Fc, a Multifunctional Agent To Battle Gram-Negative Bacteria
Philipp Gross et al.
INFECTION AND IMMUNITY (2009)
Early Use of Polymyxin B Hemoperfusion in Abdominal Septic Shock The EUPHAS Randomized Controlled Trial
Dinna N. Cruz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Intensive Insulin Therapy in Critically Ill Patients: NICE-SUGAR or Leuven Blood Glucose Target?
Greet Van den Berghe et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Intensive versus Conventional Glucose Control in Critically Ill Patients
S. Finfer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
A LONGER DURATION OF POLYMYXIN B-IMMOBILIZED FIBER COLUMN HEMOPERFUSION IMPROVES PULMONARY OXYGENATION IN PATIENTS WITH SEPTIC SHOCK
Chieko Mitaka et al.
SHOCK (2009)
ROLE OF TOLL-LIKE RECEPTORS 2 AND 4, AND THE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS IN HIGH-MOBILITY GROUP BOX 1-INDUCED INFLAMMATION IN VIVO
Marieke A. D. van Zoelen et al.
SHOCK (2009)
Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia
Evangelos J. Giamarellos-Bourboulis et al.
CLINICAL INFECTIOUS DISEASES (2008)
Randomized, double-blind, placebo-controlled trial of granulocyte colony-stimulating factor in patients with septic shock
Dianne P. Stephens et al.
CRITICAL CARE MEDICINE (2008)
Effect of insulin therapy on coagulation and fibrinolysis in medical intensive care patients
Lies Langouche et al.
CRITICAL CARE MEDICINE (2008)
Serum thrombomodulin level relates to the clinical course of disseminated intravascular coagulation, multiorgan dysfunction syndrome, and mortality in patients with sepsis
Shu-Min Lin et al.
CRITICAL CARE MEDICINE (2008)
Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008
R. Phillip Dellinger et al.
CRITICAL CARE MEDICINE (2008)
Human recombinant lactoferrin acts synergistically with antimicrobials commonly used in neonatal practice against coagulase-negative staphylococci and Candida albicans causing neonatal sepsis
Mohan Pammi Venkatesh et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2008)
The role of MAP kinase phosphatase-1 in the protective mechanism of dexamethasone against endotoxemia
Xianxi Wang et al.
LIFE SCIENCES (2008)
Hydrocortisone therapy for patients with septic shock
Charles L. Sprung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Novel potential therapies for septic shock
Luciano Cesar Pontes Azevedo et al.
SHOCK (2008)
TLR signaling pathway in patients with sepsis
Reinaldo Salomao et al.
SHOCK (2008)
Stress doses of hydrocortisone in septic shock: beneficial effects on opsonization-dependent neutrophil functions
Ines Kaufmann et al.
INTENSIVE CARE MEDICINE (2008)
Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis
Christian Bopp et al.
CRITICAL CARE (2008)
Phase II, randomized, multicenter, double-blind, placebo-controlled trial of a polyclonal anti-Staphylococcus aureus capsular polysaccharide immune globulin in treatment of Staphylococcus aureus bacteremia
Mark E. Rupp et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: A systematic review and meta-analysis
Kevin B. Laupland et al.
CRITICAL CARE MEDICINE (2007)
Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock
K. Georg Kreyrnann et al.
CRITICAL CARE MEDICINE (2007)
Pivotal involvement of Fcγ receptor IIA in the neutralization of lipopolysaccharide signaling via a potent novel anti-TLR4 monoclonal antibody 15C1
Irene Dunn-Siegrist et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Therapeutic effects of TAK-242, a novel selective Toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model
Takukyu Sha et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection
Emily C. Lutterloh et al.
CRITICAL CARE (2007)
Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review
Dinna N. Cruz et al.
CRITICAL CARE (2007)
Diagnosis of adrenal insufficiency in severe sepsis and septic shock
Djillali Annane et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Intravenous polyclonal IgM-enriched immunoglobulin therapy in sepsis:: a review of clinical efficacy in relation to microbiological aetiology and severity of sepsis
A. Norrby-Teglund et al.
JOURNAL OF INTERNAL MEDICINE (2006)
Effects of enteral feeding with eicosapentaenoic acid, γ-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock
Alessandro Pontes-Arruda et al.
CRITICAL CARE MEDICINE (2006)
Safety and efficacy of affinity-purified, anti-tumor necrosis factor-α, ovine fab for injection (CytoFab) in severe sepsis
Todd W. Rice et al.
CRITICAL CARE MEDICINE (2006)
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock
Arland Kumar et al.
CRITICAL CARE MEDICINE (2006)
Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury
P Singer et al.
CRITICAL CARE MEDICINE (2006)
Intensive insulin therapy in the medical ICU
G Van den Berghe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The effect of continuous veno-venous hemofiltration or direct hemoperfusion with polymyxin B-immobilized fiber on neutrophil respiratory oxidative burst in patients with sepsis and septic shock
T Naka et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2006)
Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome
D Annane et al.
CRITICAL CARE MEDICINE (2006)
Cost-effectiveness of immunoglobulin M-enriched immunoglobulin (Pentaglobin) in the treatment of severe sepsis and septic shock
AR Neilson et al.
JOURNAL OF CRITICAL CARE (2005)
A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection
JL Vincent et al.
SHOCK (2005)
Effects of high-dose of intravenous immunoglobulin and antibiotics on survival for severe sepsis undergoing surgery
A Rodríguez et al.
SHOCK (2005)
Hydrocortisone infusion for severe community-acquired pneumonia - A preliminary randomized study
M Confalonieri et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab1)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels
EA Panacek et al.
CRITICAL CARE MEDICINE (2004)
Immunologic and hemodynamic effects of low-dose hydrocortisone in septic shock - A double-blind, randomized, placebo-controlled, crossover study
D Keh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Enteral nutrition with eicosapentaenoic acid, γ-linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome
ER Pacht et al.
CRITICAL CARE MEDICINE (2003)
Clinical trials of immunomodulatory therapies in severe sepsis and septic shock
JL Vincent et al.
CLINICAL INFECTIOUS DISEASES (2002)
Intensive insulin therapy in critically ill patients.
G Van den Berghe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
DC Angus et al.
CRITICAL CARE MEDICINE (2001)
Efficacy and safety of recombinant human activated protein C for severe sepsis.
GR Bernard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
